An Expired Prescriber Registration and 40 Tablets of Oxycodone
At 4:40 p.m. on a Saturday, a 34-year-old man presents a paper prescription at a community pharmacy in Omaha for oxycodone HCl 15 mg tablets, quantity 120, written nine days earlier by a physician at a pain clinic 60 miles away. He has never filled at this pharmacy, and the state prescription monitoring program shows only two prior fills, both at a different pharmacy, 40 days ago. The pharmacist has 40 tablets in stock; the balance cannot arrive until Tuesday. The patient says the clinic is closed until Monday and that a receptionist told him to "fill whatever you have." Checking the prescriber, the pharmacist finds the DEA registration expired 12 days ago with a renewal pending, while the state medical license is current. Another physician in the same practice holds an active DEA registration and is listed as the covering prescriber. The pharmacy closes at 6 p.m. and is closed Sunday. The patient is paying cash and is visibly uncomfortable.
1. May the pharmacist dispense the 40 tablets today? Address the expired DEA registration and the partial-fill rules, and state exactly what must be documented.
Read the worked answer
No - not on this prescription.
A controlled substance prescription is valid only if issued for a legitimate medical purpose by an individual practitioner acting in the usual course of professional practice, and that practitioner must be registered with DEA (or exempt) at the time the prescription is issued. A registration that expired 12 days before the pharmacist examined it means the prescriber was not authorized when the prescription was written; a pending renewal does not retroactively cure the defect, and DEA does not backdate registrations. A receptionist's instruction carries no authority.
That defect is independent of the partial-fill question. Even with a valid prescription, a Schedule II partial fill is permitted only when the pharmacist cannot supply the full quantity. The quantity supplied and the date must be recorded on the face of the prescription (or in a linked record), and the remainder must be supplied within 72 hours of the partial fill; otherwise the pharmacist must notify the prescriber and no further quantity may be dispensed without a new prescription.
Document the verification attempts (DEA registration check, time, result), the refusal, and any conversation with the covering prescriber. Return the prescription and explain the options rather than dispensing 40 tablets to "tide him over."
2. Assume the registration problem is resolved and the pharmacist dispenses all 120 tablets. What obligations attach to the partial fill if only 40 are on hand, and what happens if the balance never arrives?
Read the worked answer
If the prescription is otherwise valid, the pharmacist may supply 40 tablets as a partial fill because of insufficient stock, but the record must show the quantity dispensed, the date, and the dispensing pharmacist. The 72-hour clock for the remaining 80 tablets runs from that partial fill, so the balance must be supplied no later than roughly the same time on Tuesday.
If the balance cannot be supplied within 72 hours:
- The pharmacist must notify the prescribing practitioner that the remainder was not supplied.
- No additional quantity may be dispensed on that prescription - the patient needs a new prescription for any further supply.
- The 40 tablets already dispensed remain a completed dispensing event: they must be reported to the Nebraska prescription monitoring program like any other dispensing, and the patient record must reflect the partial nature of the fill.
Note what cannot happen: the prescription cannot be transferred to a pharmacy that has stock. Schedule II prescriptions are not transferable between pharmacies for filling or refill. The pharmacist also should not "hold" the prescription past the window hoping stock arrives - the failure to notify the prescriber is itself the violation.
3. What corresponding-responsibility concerns exist here, and how should they change the analysis?
Read the worked answer
Corresponding responsibility means the pharmacist shares legal accountability for the legitimacy of every controlled substance prescription dispensed. Several signals here are individually weak but cumulatively trigger an obligation to inquire:
- Cash payment for a high-quantity immediate-release opioid.
- New patient, no local history, from a prescriber 60 miles away.
- Quantity of 120 with no evidence of prior titration or tolerance-building therapy.
- A nine-day-old prescription presented as a first fill, which can suggest shopping after an earlier refusal.
- A third party (receptionist) directing the fill rather than the prescriber.
A pharmacist should review the PMP for multiple prescribers, overlapping opioids, or a pattern of cash fills; verify the patient's identity; and ask about diagnosis, prior therapy, and whether a smaller quantity is clinically appropriate. The patient's discomfort or distress is not a basis for dispensing.
If the pharmacist cannot resolve the concerns with the prescriber, the correct action is to decline to dispense and document the specific questions asked and answers received. A defensible refusal is far safer than a fill justified by "the clinic said it was fine."